Physician Notes: Accountability Office Can't Count, Claims ASCO

Why This Topic Matters

It helps readers understand a contested Medicare payment analysis affecting oncology practices, along with other federal actions that may influence reimbursement administration and compliance oversight.

Article Sections

1. Medicare chemotherapy drug payment analysis and ASCO response

   Covers a Government Accountability Office report on oncology drug reimbursement and the association’s reaction to the findings. The section compares the two organizations’ broad perspectives on physician payment impacts.

2. HHS and CMS leadership changes

   Summarizes personnel changes affecting the Department of Health and Human Services and the Centers for Medicare & Medicaid Services. It notes leadership continuity concerns tied to ongoing federal healthcare implementation work.

3. Teaching hospital settlement and billing allegations

   Describes a federal investigation involving affiliated clinics and settlement activity related to billing practices. The section addresses allegations concerning physician involvement and level-of-service reporting.

4. CMS enrollment processing update

   Explains a CMS operational change involving carrier processing timelines for enrollment information. It outlines the general administrative update without detailing specific claim handling logic.